Pasteurized A. muciniphila

DIETARY_SUPPLEMENT3 trials

Sponsors

A-Mansia Biotech S.A., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

FMTFecal Microbiota TransplantationGut MicrobiomeIntestinal MicrobiomeIrritable Bowel SyndromeMetabolic SyndromeMicrobiomeNon Alcoholic Steatohepatitis

Phase 2

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

RecruitingNCT05821010

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Fecal Microbiota Transplantation, FMT, Gut Microbiome +6

Start: 2023-03-17End: 2026-08-20Target: 48Updated: 2024-08-27

Unknown Phase

Effect of Pasteurized Akkermansia Muciniphila on Insulin Resistance in Otherwise Healthy Subjects With Dysglycaemia

CompletedNCT05114018

A-Mansia Biotech S.A.Metabolic Syndrome, Overweight and Obesity, Pre-diabetes

Start: 2020-06-24End: 2023-08-31Updated: 2025-06-08

Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS

CompletedNCT05348642

A-Mansia Biotech S.A.Irritable Bowel Syndrome

Start: 2022-07-21End: 2023-01-06Updated: 2023-03-02

Related Papers

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis

BMJ Open2025-01-014 citations